Cheesman Hilary K, Feinbaum Rhonda L, Thekkiniath Jose, Dowen Robert H, Conery Annie L, Pukkila-Worley Read
Program in Innate Immunity, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114.
G3 (Bethesda). 2016 Jan 27;6(3):541-9. doi: 10.1534/g3.115.025650.
Inappropriate activation of innate immune responses in intestinal epithelial cells underlies the pathophysiology of inflammatory disorders of the intestine. Here we examine the physiological effects of immune hyperactivation in the intestine of the nematode Caenorhabditis elegans. We previously identified an immunostimulatory xenobiotic that protects C. elegans from bacterial infection by inducing immune effector expression via the conserved p38 MAP kinase pathway, but was toxic to nematodes developing in the absence of pathogen. To investigate a possible connection between the toxicity and immunostimulatory properties of this xenobiotic, we conducted a forward genetic screen for C. elegans mutants that are resistant to the deleterious effects of the compound, and identified five toxicity suppressors. These strains contained hypomorphic mutations in each of the known components of the p38 MAP kinase cassette (tir-1, nsy-1, sek-1, and pmk-1), demonstrating that hyperstimulation of the p38 MAPK pathway is toxic to animals. To explore mechanisms of immune pathway regulation in C. elegans, we conducted another genetic screen for dominant activators of the p38 MAPK pathway, and identified a single allele that had a gain-of-function (gf) mutation in nsy-1, the MAP kinase kinase kinase that acts upstream of p38 MAPK pmk-1. The nsy-1(gf) allele caused hyperinduction of p38 MAPK PMK-1-dependent immune effectors, had greater levels of phosphorylated p38 MAPK, and was more resistant to killing by the bacterial pathogen Pseudomonas aeruginosa compared to wild-type controls. In addition, the nsy-1(gf) mutation was toxic to developing animals. Together, these data suggest that the activity of the MAPKKK NSY-1 is tightly regulated as part of a physiological mechanism to control p38 MAPK-mediated innate immune hyperactivation, and ensure cellular homeostasis in C. elegans.
肠道上皮细胞中固有免疫反应的不适当激活是肠道炎症性疾病病理生理学的基础。在此,我们研究了线虫秀丽隐杆线虫肠道中免疫过度激活的生理效应。我们之前鉴定出一种免疫刺激性异生物质,它通过保守的p38丝裂原活化蛋白激酶(MAPK)途径诱导免疫效应器表达,从而保护秀丽隐杆线虫免受细菌感染,但对在无病原体情况下发育的线虫有毒性。为了研究这种异生物质的毒性与免疫刺激特性之间可能存在的联系,我们对秀丽隐杆线虫突变体进行了正向遗传学筛选,以寻找对该化合物有害作用具有抗性的突变体,并鉴定出了五个毒性抑制子。这些菌株在p38 MAPK盒的每个已知组分(tir-1、nsy-1、sek-1和pmk-1)中都含有亚效突变,表明p38 MAPK途径的过度刺激对动物有毒性。为了探索秀丽隐杆线虫中免疫途径的调控机制,我们对p38 MAPK途径的显性激活剂进行了另一项遗传学筛选,并鉴定出一个单一等位基因,该等位基因在位于p38 MAPK pmk-1上游的MAP激酶激酶激酶nsy-1中具有功能获得(gf)突变。与野生型对照相比,nsy-1(gf)等位基因导致p38 MAPK PMK-1依赖性免疫效应器的过度诱导出现更高水平的磷酸化p38 MAPK,并且对细菌病原体铜绿假单胞菌的杀伤更具抗性。此外,nsy-1(gf)突变对发育中的动物有毒性。这些数据共同表明,MAPKKK NSY-1的活性受到严格调控,这是控制p38 MAPK介导的固有免疫过度激活并确保秀丽隐杆线虫细胞内稳态的生理机制的一部分。